Episodes

My guest Professor Brendon Coventry, an Adelaide-based oncology surgeon suggests there may be another way to treat resistant melanomas. With a special interest in Melanoma Surgery, he is also a researcher whose interests include anti-tumour immune response in human malignancies, tumour Immunology and cancer vaccine treatments. Results of Prof Coventry et al research paper, pub 2014 titled ?Vaccinia Melanoma Cell Lysate Vaccine (VMCL) Trial for treatment of advanced Stage IV Melanoma with and w...

Like many advanced cancers, advanced Melanoma is renowned to be refractory to treatments. On today’s show, my guest Professor Brendon Coventry, an Adelaide-based oncology surgeon suggests there may be another way. With a special interest in Melanoma Surgery, he is also a researcher whose interests include anti-tumour immune response in human malignancies, tumour Immunology and cancer vaccine treatments. Results of Prof Coventry et al research paper, pub 2014 titled ?Vaccinia Melanoma Cell Lysa...